Rights and permissions
About this article
Cite this article
Glaxo Wellcome has issued a warning about zanamivir [`Relenza'] in Europe. React. Wkly. 788, 2 (2000). https://doi.org/10.2165/00128415-200007880-00001
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128415-200007880-00001